48 related articles for article (PubMed ID: 1140914)
1. Concepts and limitations in the application of radiolabeled antiandrogens, estrogens, or androgens as isotopic scanning agents for the prostate.
Berger B; Coffey DS; Scott WW
Invest Urol; 1975 Jul; 13(1):10-6. PubMed ID: 1140914
[TBL] [Abstract][Full Text] [Related]
2. Prostatic effects of a nonsteroidal antiandrogen.
Varkarakis MJ; Kirdani RY; Yamanaka H; Murphy GP; Sandberg AA
Invest Urol; 1975 Jan; 12(4):275-84. PubMed ID: 1167537
[TBL] [Abstract][Full Text] [Related]
3. Effects of castration, androgens, and estrogens on steroid levels in the dog prostate.
Varkarakis MJ; Kirdani RY; Abramczyk J; Murphy GP; Sandberg AA
Invest Urol; 1973 Sep; 11(2):106-13. PubMed ID: 4728257
[No Abstract] [Full Text] [Related]
4. Flutamide. Mechanism of action of a new nonsteroidal antiandrogen.
Sufrin G; Coffey DS
Invest Urol; 1976 May; 13(6):429-34. PubMed ID: 1270239
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroid antiandrogen inhibiting effect on testosterone metabolism in rat prostate and liver.
Reznikov A; Korpacheva T
Endocrinol Exp; 1990 Dec; 24(4):437-47. PubMed ID: 2096078
[TBL] [Abstract][Full Text] [Related]
6. The male genital tract and the nipples of male and female offspring of rats given the non-steroidal antiandrogens DIMP and Sch 13521, during pregnancy.
Ahlin K; Forsberg JG; Jacobsohn D; Thore-Berger B
Arch Anat Microsc Morphol Exp; 1975; 64(1):27-44. PubMed ID: 1217898
[TBL] [Abstract][Full Text] [Related]
7. Relative potency of antiandrogens with reference to intracellular testosterone in the rat prostate.
Kondo Y; Homma Y; Aso Y; Kawabe K; Mieda M; Takahashi H
Prostate; 1996 Sep; 29(3):146-52. PubMed ID: 8827082
[TBL] [Abstract][Full Text] [Related]
8. In utero exposure to antiandrogens alters the responsiveness of the prostate to p,p'-DDE in adult rats and may induce prostatic inflammation.
You L; Brenneman KA; Heck H
Toxicol Appl Pharmacol; 1999 Dec; 161(3):258-66. PubMed ID: 10620483
[TBL] [Abstract][Full Text] [Related]
9. Effect of cyproterone acetate in comparison to flutamide on the ventral prostate of adult male castrated Copenhagen-Fisher rats and on Dunning R-3327 H tumors.
Donn F; Becker H; Klosterhalfen H; Klein H
Andrologia; 1989; 21(5):462-7. PubMed ID: 2530921
[TBL] [Abstract][Full Text] [Related]
10. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T;
J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218
[TBL] [Abstract][Full Text] [Related]
11. Effects of castration, androgen replacement and flutamide treatment on the contractile function of the rat prostate.
Hib J; Magariños GA
Acta Physiol Pharmacol Latinoam; 1989; 39(3):281-7. PubMed ID: 2634325
[TBL] [Abstract][Full Text] [Related]
12. Flutamide metabolism in four different species in vitro and identification of flutamide metabolites in human patient urine by high performance liquid chromatography/tandem mass spectrometry.
Tevell A; Lennernäs H; Jönsson M; Norlin M; Lennernäs B; Bondesson U; Hedeland M
Drug Metab Dispos; 2006 Jun; 34(6):984-92. PubMed ID: 16540588
[TBL] [Abstract][Full Text] [Related]
13. Prostate specific antigen decreases after withdrawal of antiandrogen therapy with bicalutamide or flutamide in patients receiving combined androgen blockade.
Schellhammer PF; Venner P; Haas GP; Small EJ; Nieh PT; Seabaugh DR; Patterson AL; Klein E; Wajsman Z; Furr B; Chen Y; Kolvenbag GJ
J Urol; 1997 May; 157(5):1731-5. PubMed ID: 9112515
[TBL] [Abstract][Full Text] [Related]
14. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
Wilson MJ; Ludowese C; Sinha AA; Estensen RD
Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
[TBL] [Abstract][Full Text] [Related]
15. Response of the prostatic complex of protein deficient rats to sex hormones.
Tripathi SS; Roy SK; Kar AB
Endokrinologie; 1969; 55(3):186-93. PubMed ID: 5381114
[No Abstract] [Full Text] [Related]
16. Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens.
Whitaker HC; Hanrahan S; Totty N; Gamble SC; Waxman J; Cato AC; Hurst HC; Bevan CL
Clin Cancer Res; 2004 Nov; 10(21):7392-401. PubMed ID: 15534116
[TBL] [Abstract][Full Text] [Related]
17. Effects of two non-steroidal antiandrogens on testicular function in prepubertal rats.
Rulli SB; Gonzalez-Calvar SI; Campo S; Calandra RS
J Androl; 1995; 16(3):225-32. PubMed ID: 7559155
[TBL] [Abstract][Full Text] [Related]
18. Suppressive effects of antiandrogens, finasteride and flutamide on development of prostatic lesions in a transgenic rat model.
Cho YM; Takahashi S; Asamoto M; Suzuki S; Tang M; Shirai T
Prostate Cancer Prostatic Dis; 2007; 10(4):378-83. PubMed ID: 17457304
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha-related apoptosis-inducing ligand decoy receptor DcR2 is targeted by androgen action in the rat ventral prostate.
Vindrieux D; Réveiller M; Florin A; Blanchard C; Ruffion A; Devonec M; Benahmed M; Grataroli R
J Cell Physiol; 2006 Mar; 206(3):709-17. PubMed ID: 16245307
[TBL] [Abstract][Full Text] [Related]
20. Scanning of the prostate with Stilbostat-131I.
Zimel H; Dimitriu L; Mîndroiu T; Mateescu GH; Gălăţeanu I; Marinescu M; Arsene J
Endocrinologie; 1977; 15(2):127-31. PubMed ID: 559345
[No Abstract] [Full Text] [Related]
[Next] [New Search]
